Covid19 Clinical Trial
— PSY-CO-ICUOfficial title:
Psychological Impact of COVID-19 Outbreak on Caregivers Involved in Intensive Care Unit Patient Management: Impact on the Occurrence of Post-traumatic Stress Disorder, Anxiety, Depression and Burn Out Syndrome
Based on the experience of previous pandemics, countries reacted by applying different upgrade strategies to prevent or delay the widespread of the disease. Therefore, measures such as border closure, school closure, restrict social gathering (even shutdown of workplaces), limit population movements, and confinement meaning quarantines at the scale of cities or regions. In public hospitals, several measures have been decided to concentrate the power of care on potential wave of admissions of patients with severe forms of Covid-19. In this purpose, the number of available beds in Intensive Care Units (ICU) has been increased by two-fold and scheduled non-emergency surgical procedure have been cancelled. That means: 1. For the most severe patients, new personals (physician such as anesthesiologists, nurses of other units) have been transferred in ICUs. 2. For the less severe patients, personals of non-busy units have been transferred in busier ones. All these measures lead to major daily-life change sets that could be stressful. In the general population, it has been well documented that quarantine or confinement or isolation could lead to the occurrence of Post-Traumatic Stress Disorder (PTSD) syndrome in about 30% overall population. Importantly, high depressive symptoms have been reported in 9% of hospital staff. Numerous symptoms have been reported after quarantine or isolation such as emotional disturbance, depression, stress, low mood, irritability, insomnia, and post-traumatic stress symptoms. In hospital setting, few studies have been performed for assessing the psychological impact of quarantine and isolation. However, two studies reported a high prevalence of burn-out syndrome (BOS) in ICU physician and PTSD syndrome and depression in ICU nurses. As the consequences of all the measures decided and applied during Covid-19 pandemic could be important on caregivers, the present study primarily aims at assessing the prevalence of PTSD syndrome in a large population of caregivers implied or not in Intensive Care Units. The secondary objective were 1) to assess the prevalence of severe depression and anxiety and BOS 2) to isolate potential factors associated with PTSD, severe depression, anxiety or BOS.
Status | Not yet recruiting |
Enrollment | 5000 |
Est. completion date | September 2022 |
Est. primary completion date | September 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Caregivers (doctors senior and junior, nurses, aid nurses) involved in the staff (permanent or transient, full or partial time) of ICU patients during Covid-19 outbreak - Approved to participate Exclusion Criteria: - Participation refusal - No internet connection for responding to the questionnaire with REDCAP file |
Country | Name | City | State |
---|---|---|---|
France | Intensive Care Unit, CHU d'Amiens | Amiens | |
France | Intensive Care Unit, CHU d'Angers | Angers | |
France | CHU de Besançon | Besançon | |
France | CHU de Bordeaux, Hôpital Pellegrin | Bordeaux | |
France | Intensive care Unit CHU de Brest Hôpital Cavale Blanche | Brest | |
France | CHU de Caen | Caen | |
France | CHU de Clermont Ferrand | Clermont-Ferrand | |
France | AP-HP, Hôpital Henri Mondor | Créteil | |
France | CHU de dijon | Dijon | |
France | CHU de Grenoble, Hôpital Michalon | La Tronche | |
France | AP_HP, Hôpital du Kremlin Bicêtre | Le Kremlin-Bicêtre | |
France | Intensive Care Unit, CHRU de Lille | Lille | |
France | Intensive Care Unit, CHU de Limoges | Limoges | |
France | Hôpitaux civils de Lyon, Hôpital de la Croix Rousse | Lyon | |
France | Hôpitaux civils de Lyon, Hôpital Edouard Herriot | Lyon | |
France | Hôpitaux civils de Lyon, Hôpital Louis Pradel | Lyon | |
France | AP-HM, Hôpital e la Conception | Marseille | |
France | AP-HM, Hôpital Nord | Marseille | |
France | AP-HM, Hôpital Timone adultes, Intensive Care Unit | Marseille | |
France | AP-HM, Hôpital Timone adultes, Neurotraumatology | Marseille | |
France | CHU de Montpellier, Hôpital Guy de chauliac | Montpellier | |
France | CHU de Montpellier, Hôpital Lapeyronie | Montpellier | |
France | CHU De Montpellier, Hôpital St Eloi | Montpellier | |
France | CHU de Montpellier, Hôpital St Eloi SAR B | Montpellier | |
France | CHU De Montpellier, Hôpital St Eloi-DAR B | Montpellier | |
France | Intensive Care Unit, CHU de Mulhouse | Mulhouse | |
France | Intensive CAre Unit CHRU de Nancy, Hôpital Central | Nancy | |
France | Intensive Care Unit, CHU de Nantes | Nantes | |
France | Intensive Care Unit, CHU de Nantes, Hôtel Dieu | Nantes | |
France | CHU de Nice | Nice | |
France | Intensive care Unit CHU Nîmes | Nîmes | |
France | AP-HP, Hôpital Bichât | Paris | |
France | AP-HP, Hôpital de la Pitié | Paris | |
France | AP-HP, Hôpital Lariboisière | Paris | |
France | AP-HP, Hôpital St Antoine | Paris | |
France | AP_HP, Hôpital G Pompidou | Paris | |
France | AP6HP, Hôpital St Loui | Paris | |
France | CH de Perpignan | Perpignan | |
France | CHU de Bordeaux, Hôpital Haut Leveque | Pessac | |
France | Intensive care Unit, Hôpitaux civils de Lyon, Lyon Sud | Pierre-Bénite | |
France | CHU de Poitiers | Poitiers | |
France | Intensive care Unit CHU de Rennes | Rennes | |
France | CHU de Rouen | Rouen | |
France | CHU de St Etienne, Hôpital Nord | Saint-Étienne | |
France | Intensive Care Unit, CHU de Nantes, Hôpital Laennec | Saint-Herblain | |
France | Intesive Care Unit CHRU de Strasbourg, Hôpital civil | Strasbourg | |
France | Intesive Care Unit CHRU de Strasbourg, Hôpital Hautepierre | Strasbourg | |
France | CHU de Toulouse | Toulouse | |
France | Intensive care unit CHU de Tours | Tours | |
France | Intensive CAre Unit CHRU de Nancy, Hôpital de Brabois | VandÅ“uvre-lès-Nancy | |
France | CH de Vesoul | Vesoul |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Post-Traumatic Stress Disorder | PCL - 5 (Post-Traumatic Stress Disorder Checklist Scale, version DSM-5) | 3-6 month after the Covid-19 outbreak | |
Secondary | anxiety and depression | HADS scale (Hospital Anxiety and Depression Scale) | 3-6 month after the Covid-19 outbreak | |
Secondary | Burn out | Score MBI (Burn out syndrome) | 3-6 month after the Covid-19 outbreak |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |